UNITED STATES

Vibrent Health, a Virginia-based digital platform for next-generation precision health research has had its Digital Health Research Cloud for Government approved by the Federal Risk and Authorisation Management Program( FedRAMP). The approval means Federal agencies and research partners can slash months from ATO timelines by procuring common offthe-shelf digital tools to meet their evolving needs. Federal agencies conducting health research involving federal data must utilise FedRAMP-authorised cloud services.

CHINA

AXA Hong Kong and Macau( AXA) has launched its new AXA Health Concierge service, providing eligible customers with a comprehensive, one-stop health management solution across Hong Kong and mainland China. This initiative introduces the pioneering crossborder Green Medical Pass offering priority access to medical appointments through a network of over 2,000 healthcare providers. Hong Kong’ s healthcare system is facing significant strain as waiting times for specialist outpatient services reach a record high – making cross-border healthcare an increasingly attractive option as mainland China’ s healthcare sector has made makes significant cutting-edge advancements.

AUSTRALIA

Helfie AI, a Melbourne-based mobile health platform, has appointed two influential industry leaders to its executive team as it bids to building the world’ s first human health platform powered by AI. Stefan Kulik joins as Chief Operating Officer and Rania Awad as Chief Strategy Officer. The Helfie AI platform is intended to enable anyone with a smartphone anywhere in the world access to easy, instant and affordable health checks. Helfie AI Cofounder and CEO, George Tomeski, said:“ As we reach across communities worldwide and deliver on our vision of providing an accurate and cost-effective way for patients to obtain health checks, we will rely on their expertise of Stefan and Rania to realise this mission.”

SINGAPORE

Singapore’ s Health Sciences Authority( HSA) has approved Body Vision Medical’ s LungVision advanced imaging platform. This clearance enables full commercialisation of LungVision – a leader in AI-powered intraoperative imaging – in Singapore and represents a significant milestone in the company’ s ongoing mission to improve early and accurate diagnosis of lung cancer worldwide. Lung cancer is a significant health concern in Singapore, ranking as the second most common cancer in men and the third most common in women. Over a five-year period( 2018 – 2022), approximately 9,000 cases were diagnosed. According to the Singapore Cancer Registry, most patients are diagnosed at a late stage, reducing the effectiveness of treatment and survival rates.

www. intelligenthealth. tech 33